Skip to content

Home
About Us
Our Focus
- LVAD
- ESKD + AFib
- APS
Research & Development
Investors
Contact

Menu

Home
About Us
Our Focus
- LVAD
- ESKD + AFib
- APS
Research & Development
Investors
Contact

Contact

Advancing the development of tecarfarin for unmet needs in anticoagulation therapy

Cadrenal Therapeutics, Inc.
822 North A1A
Ponte Vedra, FL 32082

Phone: 904.300.0701

Contact

Name

Email

Message

Contact

Cadrenal Therapeutics, Inc.
822 North A1A
Ponte Vedra, FL 32082
[email protected]

Site Links

Home
Investors
Email Alerts
Privacy Policy

Home
Investors
Email Alerts
Privacy Policy

Our Company

About Us
Management Team
Board of Directors
Scientific Advisory Board

About Us
Management Team
Board of Directors
Scientific Advisory Board

Research & Development

Tecarfarin
LVAD
ESKD + AFib
APS
Pipeline
Clinical Trials

Tecarfarin
LVAD
ESKD + AFib
APS
Pipeline
Clinical Trials

Sign Up for Email Alerts

Copyright 2024 Cadrenal Therapeutics. All Rights Reserved.

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset